Aprea Therapeutics earnings were -$13.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest APRE earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$2.9M, down 23.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, APRE reported annual earnings of -$13.0M, with -9.3% growth.
What were Aprea Therapeutics's earnings last quarter?
On APRE's earnings call on Invalid Date, Aprea Therapeutics (NASDAQ: APRE) reported Q4 2024 earnings per share (EPS) of -$0.47, up 48.91% year over year. Total APRE earnings for the quarter were -$2.89 million. In the same quarter last year, Aprea Therapeutics's earnings per share (EPS) was -$0.92.
As of the last Aprea Therapeutics earnings report, Aprea Therapeutics is currently losing money. Aprea Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$12.96 million, a 9.3% decrease year over year.
What was APRE's earnings growth in the past year?
As of Aprea Therapeutics's earnings date in Invalid Date, Aprea Therapeutics's earnings has grown year over year. APRE earnings in the past year totalled -$12.96 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.